Patients with cardiovascular disease and, namely, heart failure are more susceptible to
coronavirus disease 2019 (COVID‐19) and have a more severe clinical course once …

Renin–angiotensin system (RAS) blockers are extensively used worldwide to treat many
cardiovascular disorders, where they are effective in reducing both mortality and morbidity …

Abstract Purpose of Review Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) is the virus responsible for the aggressive coronavirus disease (COVID-19) pandemic …

A close and intriguing relationship has been suggested between heart failure (HF) and
coronavirus disease 2019 (COVID-19). First, COVID-19 pandemic represented a global …

According to available clinical data,≈ 15% to 30% of the COVID-19 patients are with
hypertension and≈ 2.5% to 15% are with coronary heart disease. 3–5 …

Heart failure is a common disease state that can be encountered at different stages in the
course of a COVID-19 patient presentation. New or existing heart failure in the setting of …

In the throes of the COVID-19 crisis, a curious medical fact has emerged. The virus attacks
universally and with high efficiency; however, its most menacing progression uniquely …

During the spread of the severe acute respiratory syndrome coronavirus-2, some reports of
data still emerging and in need of full analysis indicate that certain groups of patients are at …

The novel coronavirus disease (COVID-19) outbreak, caused by SARS-CoV-2, represents
the greatest medical challenge in decades. We provide a comprehensive review of the …

On March 11, 2020, the World Health Organization declared coronavirus disease 2019
(COVID-19) a pandemic, and the reality of the situation has finally caught up to the …